127 related articles for article (PubMed ID: 30343539)
1. [COLONSCORE: THE USE OF MACHINE LEARNING OF BIG DATA TO DETECT COLORECTAL CANCER].
Cohn Adulamy M; Shalev V
Harefuah; 2018 Oct; 157(10):634-637. PubMed ID: 30343539
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
Nakama H; Kamijo N
Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
[TBL] [Abstract][Full Text] [Related]
3. [Comparison between application of fecal occult blood quantitive testing instrument and colloidal gold strip method in colorectal cancer screening].
Huang YQ; Zhang MW; Shen YZ; Ma HQ; Cai SR; Zhang SZ; Zheng S
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):747-51. PubMed ID: 24246083
[TBL] [Abstract][Full Text] [Related]
4. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
5. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
6. Application of the fecal microRNA test to the residuum from the fecal occult blood test.
Yamazaki N; Koga Y; Yamamoto S; Kakugawa Y; Otake Y; Hayashi R; Saito N; Matsumura Y
Jpn J Clin Oncol; 2013 Jul; 43(7):726-33. PubMed ID: 23677957
[TBL] [Abstract][Full Text] [Related]
7. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
8. Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study.
Nakama H; Kamijo N; Abdul Fattah AS; Zhang B
J Med Screen; 1996; 3(2):63-5. PubMed ID: 8849761
[TBL] [Abstract][Full Text] [Related]
9. [New criteria for detecting occult hemorrhage in screening for colorectal cancer].
Ottó S
Orv Hetil; 2001 Jul; 142(29):1541-5. PubMed ID: 11494745
[TBL] [Abstract][Full Text] [Related]
10. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
Haug U; Hundt S; Brenner H
Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
[TBL] [Abstract][Full Text] [Related]
11. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
12. [Fecal occult blood test and mass screening for colorectal cancer].
Saito H; Soma Y; Kawaguchi H
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2232-40. PubMed ID: 1929443
[TBL] [Abstract][Full Text] [Related]
13. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
Sharma VK; Corder FA; Fancher J; Howden CW
Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
[TBL] [Abstract][Full Text] [Related]
14. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
[TBL] [Abstract][Full Text] [Related]
15. FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.
Borges LV; Mattar R; Silva JMKD; Silva ALWD; Carrilho FJ; Hashimoto CL
Arq Gastroenterol; 2018; 55(2):128-132. PubMed ID: 30043860
[TBL] [Abstract][Full Text] [Related]
16. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
Brenner H; Hoffmeister M; Birkner B; Stock C
Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
[TBL] [Abstract][Full Text] [Related]
17. Population colorectal cancer screening with fecal occult blood test.
Rennert G; Rennert HS; Miron E; Peterburg Y
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
[TBL] [Abstract][Full Text] [Related]
18. [Screening for colorectal cancer and polyps].
Krieger Y; Fraser D; Odes HS; Krugliak P; Fraser GM
Harefuah; 1992 Mar; 122(6):354-6, 408. PubMed ID: 1582622
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
